Effect of skeletal muscle loss during neoadjuvant imatinib therapy on clinical outcomes in patients with locally advanced GIST

BACKGROUND: Currently, the effect of skeletal muscle loss during neoadjuvant imatinib therapy on clinical outcomes in patients with locally advanced gastrointestinal stromal tumors (LA-GIST) remains unclear. This study aims to investigate the relationship between changes in skeletal muscle and posto...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Ping’an, Guo, Honghai, He, Xiaoxiao, Sun, Chenyu, Lowe, Scott, Bentley, Rachel, Zhou, Qin, Yang, Peigang, Tian, Yuan, Liu, Yang, Yang, Li, Zhao, Qun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413907/
https://www.ncbi.nlm.nih.gov/pubmed/36028812
http://dx.doi.org/10.1186/s12876-022-02479-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413907/
https://www.ncbi.nlm.nih.gov/pubmed/36028812
http://dx.doi.org/10.1186/s12876-022-02479-4

Ejemplares similares